Selected indicators of the antioxidant system in the blood of patients with lower limb varicose veins;Wybrane wskaźniki układu antyoksydacyjnego we krwi chorych z żylakami kończyn dolnych

Acta Angiologica

Volumn 15, Issue 1, 2009, Pages 10-19

  Krzyściak, Wirginia ^a   Kózka, Mariusz ^a   Kazek, Grzegorz ^a   Stȩpniewski, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antioxidant status; Ferric reducing ability of plasma (FRAP) level; Malondialdehyde (MDA) plasma concentrations; Varicose veins

Indexed keywords

FERRIC ION; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL INDICATOR; FEMALE; HUMAN; LEG VARICOSIS; LIPID PEROXIDATION; MALE; OXIDATION; PERIPHERAL VEIN; SAPHENOUS VEIN; ULNA; VENOUS BLOOD;

EID: 67649515084     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jawień A (2003) Prevelence of chronic venous insufficiency in men and women - the Polish multicentre cross sectioned study in 40095 patients. Phlebology, 18: 110-122. (Pubitemid 37187207)
2. Wali MA, Suleiman A, Kadoumi OF et al (2002) Superoxide Radical Concentration and Superoxide Dismutase (SOD) Enzyme Activity in Varicose Veins. Ann Thorac Cardiovasc Surg, 8: 286-290.
3. Alexander CJ (1972) The theoretical basis of varicose vein formation. Med J Aust, 1: 258-261.
4. Ludbrook J (1986) Primary great saphenous veins revisited. World J Surg, 10: 94-98.
5. Burnard KG, Pattison M, Powell S et al (1986) Can we diagnose long saphenous vein incompetence correctly? John Libbey Phlebology, London 1986.
6. Nicolaides AN (2005) Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology, 56 (supl 1): 11-19.
7. Robertson L, Evans C, Fowkes FG (2008) Epidemiology of chronic venous disease. Phlebology, 23: 103-111.
8. Flora SJ (2007) Role of free radicals and antioxidants in health and disease. Cell Mol Biol, 53: 1-2. (Pubitemid 46799686)
9. Heistad DD (2006) Oxidative Stress and Vascular Disease: 2005 Duff Lecture. Arterioscler Thromb Vasc Biol, 26: 689-695.
10. Dröge W (2002) Free Radicals in the Physiological Control of Cell Function. Physiol Rev, 82: 47-95. (Pubitemid 34654215)
11. Cordis GA, Das DK, Riedel W (1998) High-performance liquid chromatographic peak identification of 2, 4-dinitro-phenylhydrazine derivatives of lipid peroxidation aldehydes by photodiode array detection. J Chromatogr A, 798: 117-123. (Pubitemid 28144451)
12. Slatter DA, Bolton CH, Bailey AJ (2000) The importance of lipid-derived malondialdehyde in diabetes mellitus. Dia-betologia, 43: 550-557. (Pubitemid 30322071)
13. Pilz J, Meineke I, Gleiter CH (2000) Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2, 4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci, 742: 315-325. (Pubitemid 30331049)
14. Rizvi SI, Jha R, Maurya PK (2006) Erythrocyte Plasma Membrane Redox System in Human Aging. Rejuvenation Research, 9: 470-474. (Pubitemid 46100668)
15. Eklöf B, Rutherford RB, Bergan JJ et al (2004) for the American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification, Helsingborg, Sweden. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasc Surg, 40: 1248-1252.
16. Buege JA, Aust SD (1978) Lipid peroxidation. Methods Enzymol, 51: 302-310.
17. Benzie F, Iris F, Strain JJ(1996) Analyt Biochem, 239: 70-76.
18. R Development Core Team (2008) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available on http://www.R-project.org.
19. Bertrand C, Batt AM (2003) Cytochromes P450, vasculartone varicosis. Ann Pharm Fr, 61: 234-242.
20. Pascarella L, Schonbein GW, Bergan JJ (2005) Microcirculation and venous ulcers: a review. Ann Vasc Surg; 19: 921-927.
21. Derin N, Izgut-Uysal VN, Agac A, Aliciguzel Y, Demir N (2004) L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J Physiol Pharmacol, 55: 595-606. (Pubitemid 39318851)
22. Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidase tissue injury. Free Radic Biol Med, 9: 515-540. (Pubitemid 120036914)
23. Riedel W, Lang U, Oetjen U, Schlapp U, Shibata M (2003) Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol Cell Biochem, 247: 83-94. (Pubitemid 36798512)
24. Annoopkumar-Dukie S, Walker RB, Daya S (2001) A sensitive and reliable method for the detection of lipid pero-xidation in biological tissues. J Pharm Pharmacol, 53: 263-266. (Pubitemid 32156522)
25. Wali MA, Suleiman A, Kadoumi OF i Nasr MA (2002) Superoxide Radicals Concentration and Superoxide Dismutase (SOD) Enzyme Activity in Varicose Vein. Ann Thorac Cardiovasc Surg, 8: 286-290.
26. Tryankina SA, Kolobova Ol, Varshavsky BY (2003) Lipid peroxidation in pathogenesis of varix dilatation. Klin Diagn Lab, 6: 19-20.
27. Wlaschek M, Scharffetter-Kochanek K (2005) Oxidative stress in chronic vein leg ulcers. Wound Rep Reg, 13: 452-461. (Pubitemid 41783163)
28. James TJ, Hughes MA, Cherry GW, Taylor RP (2003) Evidence of oxidative stress in chronic venous ulcers. Wound Rep Reg, 11: 172-176. (Pubitemid 36648874)